Single cell sequencing reveals that CD39 inhibition mediates changes to the tumor microenvironment

Abstract

The molecular mechanisms underlying tumour heterogeneity in bladder cancer remain to be explored. Here, the authors perform single cell RNA sequencing and identify CD39 as a potential target for immunotherapy, which they validate in vivo.